We investigated genetic variations driving young age-at-diabetes-diagnosis (ADD) and developed a genetic risk score (GRS) to identify Chinese individuals at risk of young-onset diabetes (YOD with ADD<40). We performed genome-wide association studies (GWAS) for ADD with internal and external replication in 22,611 indivi...
B. Fan, Claudia H. T. Tam, A. Luk et al.· Genome Medicine· 0 citations
The use of monoclonal antibodies (mAbs) has revolutionized the treatment of autoimmune, inflammatory, and neoplastic diseases. However, accumulating evidence indicates that biologic therapies may be associated with renal adverse events, including various types of glomerulonephritis. The aim of this review was to summar...
M. Miedziaszczyk, Gracjan Kosiorowski, Janusz Kubasik et al.· Frontiers in Pharmacology· 0 citations
Urinary cystatin C (uCysC) has emerged as an endogenous biomarker for renal impairment. In managing renal pathologies, early screening and monitoring of disease progression are crucial for both at-risk individuals and diagnosed patients. The ultimate goal is to prevent and mitigate the associated risks of morbidity and...
Lok Tim Pang, Miu-Ling Lam, C. Szeto et al.· ACS Sensors· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.